Clover Health Investments Target of Unusually High Options Trading (NASDAQ:CLOV)

Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) was the target of some unusual options trading on Friday. Investors bought 39,909 call options on the company. This is an increase of approximately 47% compared to the average daily volume of 27,120 call options.

Analyst Ratings Changes

Several research firms recently weighed in on CLOV. UBS Group started coverage on Clover Health Investments in a research report on Monday, October 7th. They set a "neutral" rating and a $4.00 target price on the stock. Craig Hallum began coverage on shares of Clover Health Investments in a report on Tuesday, December 17th. They set a "buy" rating and a $6.00 price objective on the stock.

Institutional Investors Weigh In On Clover Health Investments

Several institutional investors have recently bought and sold shares of CLOV. Forum Financial Management LP lifted its position in Clover Health Investments by 33.8% during the 3rd quarter. Forum Financial Management LP now owns 16,077 shares of the company's stock worth $45,000 after acquiring an additional 4,061 shares in the last quarter. Steph & Co. raised its stake in shares of Clover Health Investments by 33.3% during the fourth quarter. Steph & Co. now owns 20,000 shares of the company's stock valued at $63,000 after purchasing an additional 5,000 shares during the period. SignalPoint Asset Management LLC lifted its position in shares of Clover Health Investments by 6.2% during the fourth quarter. SignalPoint Asset Management LLC now owns 160,074 shares of the company's stock worth $504,000 after purchasing an additional 9,390 shares in the last quarter. Bleakley Financial Group LLC boosted its stake in shares of Clover Health Investments by 98.9% in the third quarter. Bleakley Financial Group LLC now owns 20,090 shares of the company's stock valued at $57,000 after purchasing an additional 9,988 shares during the period. Finally, Concurrent Investment Advisors LLC acquired a new stake in Clover Health Investments during the 3rd quarter valued at $28,000. 19.77% of the stock is currently owned by hedge funds and other institutional investors.

Clover Health Investments Stock Up 3.0 %

Shares of NASDAQ CLOV traded up $0.14 during trading on Friday, hitting $4.82. 10,241,193 shares of the company traded hands, compared to its average volume of 5,417,991. The firm has a market capitalization of $2.42 billion, a P/E ratio of -24.10 and a beta of 1.95. The company has a 50-day moving average price of $3.48 and a 200-day moving average price of $3.11. Clover Health Investments has a 1 year low of $0.61 and a 1 year high of $4.87.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.03) by $0.01. The firm had revenue of $330.99 million during the quarter, compared to the consensus estimate of $347.60 million. Clover Health Investments had a negative return on equity of 25.46% and a negative net margin of 5.92%. During the same quarter in the previous year, the business earned ($0.09) earnings per share. Research analysts predict that Clover Health Investments will post -0.12 EPS for the current fiscal year.

Clover Health Investments Company Profile

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.